Finance

Lists
SVE:WSE
Synthaverse SA
2,79 PLN
-1,06%
(-0,030) 1D
14-окт., 14:16:04 GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for SVE...
Open
2,82 PLN
High
2,82 PLN
Low
2,78 PLN
Mkt. cap
213,99 млн
Avg. vol.
34,66 миң
Volume
42,53 миң
52-wk high
4,34 PLN
52-wk low
2,60 PLN
Shares outstanding
76,02 млн
No. of employees
214
Open
2,82 PLN
High
2,82 PLN
Low
2,78 PLN
Mkt. cap
213,99 млн
Avg. vol.
34,66 миң
Volume
42,53 миң
52-wk high
4,34 PLN
52-wk low
2,60 PLN
Shares outstanding
76,02 млн
No. of employees
214
News stories
From web sources and news partners
Profile
Synthaverse S.A., formerly known as Biomed-Lublin Wytwórnia Surowic i Szczepionek is a Polish pharmaceutical company operating since 1944. The company manufactures medicinal preparations. The company's headquarters is in Lublin. Wikipedia
About Synthaverse SA
CEO-
Employees214
Founded1944
Headquarters-
Sector-
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
4,79 млн
17,51 млн
13,61 млн
12,85 млн
Cost of goods sold
3,12 млн
8,05 млн
6,43 млн
5,40 млн
Cost of revenue
3,12 млн
8,05 млн
6,43 млн
5,40 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,38 млн
10,86 млн
10,25 млн
11,29 млн
Operating expense
9,07 млн
17,01 млн
7,88 млн
8,09 млн
Total operating expenses
12,20 млн
25,06 млн
14,31 млн
13,49 млн
Operating income
-7,41 млн
-7,55 млн
-701,00 миң
-641,00 миң
Other non operating income
-357,00 миң
64,00 миң
-
-1,00 миң
EBT including unusual items
-8,96 млн
-8,71 млн
-4,14 млн
-3,42 млн
EBT excluding unusual items
-8,96 млн
-8,46 млн
-4,18 млн
-3,38 млн
Income tax expense
-1,24 млн
-1,80 млн
-537,00 миң
-656,00 миң
Effective tax rate
13,78%
20,72%
12,96%
19,20%
Other operating expenses
689,00 миң
6,15 млн
-2,37 млн
-3,20 млн
Net income
-7,72 млн
-6,90 млн
-3,61 млн
-2,76 млн
Net profit margin
-161,27%
-39,43%
-26,50%
-21,48%
Earnings per share
-
-
-
-
Interest and investment income
-
535,00 миң
-
-
Interest expense
-1,20 млн
-1,49 млн
-2,58 млн
-3,63 млн
Net interest expenses
-1,20 млн
-956,00 миң
-2,58 млн
-3,63 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,20 млн
-5,56 млн
2,67 млн
2,74 млн
Gain or loss from assets sale
-
-250,00 миң
-
-
AI content may include mistakes. Learn more
Google колдонмолору